|
negative regulation of endothelial cell differentiation
|
GO_0045602 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of endothelial cell differentiation.] |
|
positive regulation of endothelial cell development
|
GO_1901552 |
[Any process that activates or increases the frequency, rate or extent of endothelial cell development.] |
|
malonic acid transport
|
GO_1900752 |
[The directed movement of a malonic acid into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.] |
|
response to paracetamol
|
GO_1901554 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a paracetamol stimulus.] |
|
obsolete response to paclitaxel
|
GO_1901555 |
[OBSOLETE. Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a paclitaxel stimulus.] |
|
response to candesartan
|
GO_1901556 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a candesartan stimulus.] |
|
response to fenofibrate
|
GO_1901557 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fenofibrate stimulus.] |
|
response to metformin
|
GO_1901558 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a metformin stimulus.] |
|
response to ribavirin
|
GO_1901559 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ribavirin stimulus.] |
|
response to purvalanol A
|
GO_1901560 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a purvalanol A stimulus.] |
|
response to purine-containing compound
|
GO_0014074 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a purine-containing compound stimulus.] |
|
aspyridone B catabolic process
|
GO_1901520 |
[The chemical reactions and pathways resulting in the breakdown of aspyridone B.] |
|
aspyridone B biosynthetic process
|
GO_1901521 |
[The chemical reactions and pathways resulting in the formation of aspyridone B.] |
|
obsolete positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus
|
GO_1901522 |
[OBSOLETE. Any positive regulation of transcription from RNA polymerase II promoter that is involved in cellular response to chemical stimulus.] |
|
icosanoid catabolic process
|
GO_1901523 |
[The chemical reactions and pathways resulting in the breakdown of icosanoid.] |
|
fatty acid derivative catabolic process
|
GO_1901569 |
[The chemical reactions and pathways resulting in the breakdown of fatty acid derivative.] |
|
regulation of mitophagy
|
GO_1901524 |
[Any process that modulates the frequency, rate or extent of macromitophagy.] |
|
regulation of autophagy of mitochondrion
|
GO_1903146 |
[Any process that modulates the frequency, rate or extent of mitochondrion degradation by an autophagic process.] |
|
regulation of macroautophagy
|
GO_0016241 |
[Any process that modulates the frequency, rate or extent of macroautophagy.] |
|
negative regulation of mitophagy
|
GO_1901525 |
[Any process that stops, prevents or reduces the frequency, rate or extent of mitophagy.] |